Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(2.26)
# 2,764
Out of 4,984 analysts
811
Total ratings
39.32%
Success rate
-1.32%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ATYR aTyr Pharma | Downgrades: Neutral | n/a | $1.02 | - | 10 | Sep 15, 2025 | |
KRYS Krystal Biotech | Reiterates: Buy | $240 | $155.08 | +54.76% | 34 | Sep 15, 2025 | |
GUTS Fractyl Health | Initiates: Buy | $9 | $1.00 | +800.00% | 1 | Sep 15, 2025 | |
CAPR Capricor Therapeutics | Reiterates: Buy | $24 | $6.21 | +286.78% | 25 | Sep 11, 2025 | |
TVTX Travere Therapeutics | Reiterates: Buy | $47 | $22.97 | +104.61% | 4 | Sep 10, 2025 | |
LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $1.09 | +268.66% | 23 | Sep 2, 2025 | |
TNYA Tenaya Therapeutics | Reiterates: Buy | $5 | $1.27 | +294.01% | 18 | Sep 2, 2025 | |
NEUP Neuphoria Therapeutics | Reiterates: Buy | $21 | $11.21 | +87.33% | 2 | Aug 26, 2025 | |
LSTA Lisata Therapeutics | Reiterates: Buy | $15 | $2.31 | +548.34% | 17 | Aug 21, 2025 | |
FBIO Fortress Biotech | Maintains: Buy | $26 → $17 | $3.47 | +390.62% | 4 | Aug 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $25.56 | +64.32% | 36 | Aug 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.49 | +2,943.21% | 16 | Aug 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $102 | $23.77 | +329.20% | 34 | Aug 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.32 | +763.93% | 29 | Aug 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $7.79 | +105.39% | 21 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $8.60 | +248.84% | 1 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $6.42 | +55.76% | 10 | Aug 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.30 | - | 23 | Jul 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.17 | +1,011.11% | 32 | Jul 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $14.15 | +196.82% | 1 | Jun 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.13 | +557.28% | 2 | Jun 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $53 | $64.98 | -18.44% | 2 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.66 | +141.69% | 31 | Jun 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.40 | +542.86% | 12 | Jun 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.39 | +925.64% | 2 | Jun 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.78 | +475.54% | 29 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $4.44 | +35.14% | 1 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.76 | +591.49% | 14 | Jun 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.97 | +408.91% | 3 | Jun 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.79 | - | 4 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $37.75 | +175.53% | 24 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.98 | +201.71% | 15 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.75 | +871.43% | 1 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $13.28 | +141.05% | 6 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.14 | +409.55% | 12 | May 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $11.52 | +2,070.14% | 3 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.68 | +1,223.53% | 1 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $2.03 | +787.01% | 30 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.28 | +383.09% | 26 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $3.64 | +559.34% | 18 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $48.94 | +145.20% | 48 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $9.98 | +60.32% | 19 | Apr 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.15 | - | 9 | Apr 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $6.30 | +392.06% | 31 | Apr 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.78 | +574.16% | 1 | Apr 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.10 | - | 18 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $14.47 | +155.70% | 17 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.66 | +562.65% | 7 | Mar 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $34.89 | +63.37% | 26 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.48 | +1,251.35% | 14 | Jan 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.65 | +1,415.15% | 16 | Dec 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.06 | +717.96% | 4 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.62 | +6,070.93% | 7 | May 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.87 | - | 6 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $0.20 | +15,725.91% | 4 | Feb 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.42 | +2,016.40% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.82 | - | 2 | Jan 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $32.75 | +0.76% | 2 | Nov 14, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $9.66 | +707.45% | 1 | Mar 24, 2017 |
aTyr Pharma
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.02
Upside: -
Krystal Biotech
Sep 15, 2025
Reiterates: Buy
Price Target: $240
Current: $155.08
Upside: +54.76%
Fractyl Health
Sep 15, 2025
Initiates: Buy
Price Target: $9
Current: $1.00
Upside: +800.00%
Capricor Therapeutics
Sep 11, 2025
Reiterates: Buy
Price Target: $24
Current: $6.21
Upside: +286.78%
Travere Therapeutics
Sep 10, 2025
Reiterates: Buy
Price Target: $47
Current: $22.97
Upside: +104.61%
Lexicon Pharmaceuticals
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.09
Upside: +268.66%
Tenaya Therapeutics
Sep 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.27
Upside: +294.01%
Neuphoria Therapeutics
Aug 26, 2025
Reiterates: Buy
Price Target: $21
Current: $11.21
Upside: +87.33%
Lisata Therapeutics
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $2.31
Upside: +548.34%
Fortress Biotech
Aug 21, 2025
Maintains: Buy
Price Target: $26 → $17
Current: $3.47
Upside: +390.62%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $25.56
Upside: +64.32%
Aug 20, 2025
Reiterates: Buy
Price Target: $15
Current: $0.49
Upside: +2,943.21%
Aug 19, 2025
Reiterates: Buy
Price Target: $102
Current: $23.77
Upside: +329.20%
Aug 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.32
Upside: +763.93%
Aug 13, 2025
Reiterates: Buy
Price Target: $16
Current: $7.79
Upside: +105.39%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $8.60
Upside: +248.84%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $6.42
Upside: +55.76%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $1.17
Upside: +1,011.11%
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $14.15
Upside: +196.82%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.13
Upside: +557.28%
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $64.98
Upside: -18.44%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.66
Upside: +141.69%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.40
Upside: +542.86%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.39
Upside: +925.64%
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $2.78
Upside: +475.54%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $4.44
Upside: +35.14%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.76
Upside: +591.49%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.97
Upside: +408.91%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.79
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $37.75
Upside: +175.53%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $2.98
Upside: +201.71%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.75
Upside: +871.43%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $13.28
Upside: +141.05%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $3.14
Upside: +409.55%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $11.52
Upside: +2,070.14%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.68
Upside: +1,223.53%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $2.03
Upside: +787.01%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $8.28
Upside: +383.09%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $3.64
Upside: +559.34%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $48.94
Upside: +145.20%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $9.98
Upside: +60.32%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.15
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $6.30
Upside: +392.06%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $1.78
Upside: +574.16%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.10
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $14.47
Upside: +155.70%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.66
Upside: +562.65%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $34.89
Upside: +63.37%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.48
Upside: +1,251.35%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $1.65
Upside: +1,415.15%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.06
Upside: +717.96%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.62
Upside: +6,070.93%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.87
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $0.20
Upside: +15,725.91%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.42
Upside: +2,016.40%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.82
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $32.75
Upside: +0.76%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $9.66
Upside: +707.45%